{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:49:26Z","timestamp":1790837366789,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,13]],"date-time":"2022-06-13T00:00:00Z","timestamp":1655078400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009326","name":"Cancer Research Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000027","name":"CIHR ICR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000156","name":"FRQS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.lanepe.2022.100454","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T13:36:56Z","timestamp":1656596216000},"page":"100454","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9776-866X","authenticated-orcid":false,"given":"Anastasiya","family":"Muntyanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Nechaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2179-612X","authenticated-orcid":false,"given":"Elena","family":"Pastukhova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Rahme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Netchiporouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei","family":"Zubarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0562-4675","authenticated-orcid":false,"given":"Ivan V.","family":"Litvinov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lanepe.2022.100454_bib0001","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.lanepe.2022.100454_bib0002","unstructured":"WHO. Cervical cancer elimination initiative. 2020. https:\/\/www.who.int\/initiatives\/cervical-cancer-elimination-initiative."},{"issue":"3","key":"10.1016\/j.lanepe.2022.100454_bib0003","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100454_bib0004","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.lanepe.2022.100454_bib0005","article-title":"Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors","volume":"5","author":"Arbyn","year":"2018","journal-title":"Cochr Database Syst Rev"},{"issue":"10197","key":"10.1016\/j.lanepe.2022.100454_bib0006","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.lanepe.2022.100454_bib0007","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1056\/NEJMoa1917338","article-title":"HPV vaccination and the risk of invasive cervical cancer","volume":"383","author":"Lei","year":"2020","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.lanepe.2022.100454_bib0008","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-1968","article-title":"Prevalence of HPV after introduction of the vaccination program in the United States","volume":"137","author":"Markowitz","year":"2016","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100454_bib0009","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1016\/S2214-109X(20)30022-X","article-title":"Effects of updated demography, disability weights, and cervical cancer burden on estimates of human papillomavirus vaccination impact at the global, regional, and national levels: a PRIME modelling study","volume":"8","author":"Abbas","year":"2020","journal-title":"Lancet Glob Health"},{"issue":"7","key":"10.1016\/j.lanepe.2022.100454_bib0010","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(16)30099-7","article-title":"Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis","volume":"4","author":"Bruni","year":"2016","journal-title":"Lancet Glob Health"},{"issue":"8","key":"10.1016\/j.lanepe.2022.100454_bib0011","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1002\/ijc.25525","article-title":"Trends in cervical cancer incidence and mortality in the Baltic countries, Bulgaria and Romania","volume":"128","author":"Arbyn","year":"2011","journal-title":"Int J Cancer"},{"issue":"suppl 2","key":"10.1016\/j.lanepe.2022.100454_bib0012","first-page":"7","article-title":"The burden of cervical cancer in south-east Europe at the beginning of the 21st century","volume":"31","author":"Arbyn","year":"2007","journal-title":"Coll Antropol"},{"key":"10.1016\/j.lanepe.2022.100454_bib0013","unstructured":"Major milestone reached as 100 countries have introduced HPV vaccine into national schedule. 2019.https:\/\/www.who.int\/news\/item\/31-10-2019-major-milestone-reached-as-100-countries-have-introduced-hpv-vaccine-into-national-schedule."},{"issue":"12","key":"10.1016\/j.lanepe.2022.100454_bib0014","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"von Elm","year":"2014","journal-title":"Int J Surg"},{"key":"10.1016\/j.lanepe.2022.100454_bib0015","unstructured":"Kaprina AD, Starinsky VV, Petrova GV. Malignant neoplasma in Russia in 2017 (morbidity and mortality). Russia, Moscow: P.A. Herzen branch of the FGBU \u201cNMITS of radiology\u201d of the Ministry of Health; 2018."},{"key":"10.1016\/j.lanepe.2022.100454_bib0016","series-title":"Malignant Neoplasms in Russia Review of Statistical Information for 1993\u20132013","author":"Petrova","year":"2015"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100454_bib0017","first-page":"95","article-title":"Population-based registry of cancer patients in the Russian Federation","volume":"5","author":"VS","year":"2019","journal-title":"Public Health Panorama"},{"key":"10.1016\/j.lanepe.2022.100454_bib0018","unstructured":"Spiegelman M. Introduction to demography, Revised Edition - Formula 4.29; 1969."},{"issue":"2","key":"10.1016\/j.lanepe.2022.100454_bib0019","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jaad.2018.07.041","article-title":"Cutaneous malignant melanoma incidence and mortality trends in Canada: a comprehensive population-based study","volume":"80","author":"Ghazawi","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lanepe.2022.100454_bib52","article-title":"Population-based study detailing cutaneous melanoma incidence and mortality trends in Canada","volume":"9","author":"Conte","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.lanepe.2022.100454_bib0020","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000507617","article-title":"Geographic variations in cutaneous melanoma distribution in the Russian Federation","volume":"236","author":"Muntyanu","year":"2020","journal-title":"Dermatology"},{"issue":"6","key":"10.1016\/j.lanepe.2022.100454_bib0021","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1159\/000512454","article-title":"Non-melanoma skin cancer distribution in the Russian Federation","volume":"237","author":"Muntyanu","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.lanepe.2022.100454_bib0022","unstructured":"Extension of the All-Russian Population Census (\u0412\u0441\u0435\u0440\u043e\u0441\u0441\u0438\u0439\u0441\u043a\u043e\u0439 \u043f\u0435\u0440\u0435\u043f\u0438\u0441\u0438 \u043d\u0430\u0441\u0435\u043b\u0435\u043d\u0438\u044f 2010) and in collaboration with the Russian Ministry of Justice (\u041c\u0438\u043d\u044e\u0441\u0442\u0430 \u0420\u0424). 2010."},{"key":"10.1016\/j.lanepe.2022.100454_bib0023","unstructured":"Petrova GV, Gretsova OP, Kaprina AD, Starinsky VV. Characteristics and methods of calculating medical and statistical indicators used in oncology. Moscow: FGBU MNII P.A. Herzen of the Ministry of Health of the Russian Federation; 2014."},{"key":"10.1016\/j.lanepe.2022.100454_bib0024","unstructured":"GOST 7.67-2003. System of standards on information LAPCNCFT.http:\/\/protect.gost.ru\/v.aspx?control=8&baseC=-1&page=0&month=-1&year=-1&search=&RegNum=1&DocOnPageCount=15&id=121716&pageK=E38E821F-AB20-4B3B-9445-4E14301C2C07. Accessed 21 August 2019."},{"key":"10.1016\/j.lanepe.2022.100454_bib0025","unstructured":"Bruni L AG, Serrano B, Mena M, et\u00a0al. Human papillomavirus and related diseases in Russian Federation. Summary Report 17 June 2019. ICO\/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2019."},{"issue":"4","key":"10.1016\/j.lanepe.2022.100454_bib0026","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000156481","article-title":"Co-expression of HSV2 and Chlamydia trachomatis in HPV-positive cervical cancer and cervical intraepithelial neoplasia lesions is associated with aberrations in key intracellular pathways","volume":"51","author":"Paba","year":"2008","journal-title":"Intervirology"},{"issue":"21","key":"10.1016\/j.lanepe.2022.100454_bib0027","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1093\/jnci\/94.21.1604","article-title":"Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer","volume":"94","author":"Smith","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100454_bib0028","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/s00404-013-3122-3","article-title":"Chlamydia trachomatis infection: implications for HPV status and cervical cancer","volume":"289","author":"Silva","year":"2014","journal-title":"Arch Gynecol Obstet"},{"issue":"8853","key":"10.1016\/j.lanepe.2022.100454_bib0029","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/0140-6736(93)93128-N","article-title":"Antibodies to human papillomavirus and to other genital infectious agents and invasive cervical cancer risk","volume":"341","author":"Jha","year":"1993","journal-title":"Lancet (London, England)"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100454_bib0030","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/sextrans-2016-053046","article-title":"Patterns of prevalent HPV and STI co-infections and associated factors among HIV-negative young Western Cape, South African women: the EVRI trial","volume":"94","author":"Menezes","year":"2018","journal-title":"Sex Transm Infect"},{"issue":"3","key":"10.1016\/j.lanepe.2022.100454_bib0031","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1055-9965.EPI-04-0569","article-title":"Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening","volume":"14","author":"Bray","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.lanepe.2022.100454_bib0032","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/1055-9965.EPI-05-0577","article-title":"Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys","volume":"15","author":"Vaccarella","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100454_bib0033","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3892\/mco.2021.2294","article-title":"Investigation of the association between ten pathogens causing sexually transmitted diseases and high-risk human papilloma virus infection in Shanghai","volume":"15","author":"Xie","year":"2021","journal-title":"Mol Clin Oncol"},{"issue":"3","key":"10.1016\/j.lanepe.2022.100454_bib0034","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1136\/sextrans-2011-050306","article-title":"Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain","volume":"88","author":"Johnson","year":"2012","journal-title":"Sex Transm Infect"},{"issue":"9548","key":"10.1016\/j.lanepe.2022.100454_bib0035","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/S0140-6736(06)69479-8","article-title":"Sexual behaviour in context: a global perspective","volume":"368","author":"Wellings","year":"2006","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100454_bib0036","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1200\/JGO.2015.001701","article-title":"Collision of three pandemics: the coexistence of cervical cancer, HIV infection, and prior tuberculosis in the Sub-Saharan Country of Botswana","volume":"2","author":"Zetola","year":"2016","journal-title":"J Glob Oncol"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100454_bib0037","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1186\/s12885-021-08391-6","article-title":"Cancer risk in tuberculosis patients in a high endemic area","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100454_bib0038","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/jjco\/hyy158","article-title":"Cigarette smoking and cervical cancer risk: an evaluation based on a systematic review and meta-analysis among Japanese women","volume":"49","author":"Sugawara","year":"2018","journal-title":"Jpn J Clin Oncol"},{"issue":"11","key":"10.1016\/j.lanepe.2022.100454_bib0039","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S1470-2045(09)70326-2","article-title":"A review of human carcinogens\u2014Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish","volume":"10","author":"Secretan","year":"2009","journal-title":"Lancet Oncol"},{"issue":"24","key":"10.1016\/j.lanepe.2022.100454_bib0040","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1093\/jnci\/djr483","article-title":"Preventable exposures associated with human cancers","volume":"103","author":"Cogliano","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"10.1016\/j.lanepe.2022.100454_bib0041","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/tc.2006.019455","article-title":"Trends in the prevalence of smoking in Russia during the transition to a market economy","volume":"16","author":"Perlman","year":"2007","journal-title":"Tob Control"},{"issue":"1","key":"10.1016\/j.lanepe.2022.100454_bib0042","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0b013e328333fb3a","article-title":"Alcohol and gynecological cancers: an overview","volume":"19","author":"Hjartaker","year":"2010","journal-title":"Eur J Cancer Prev"},{"issue":"8","key":"10.1016\/j.lanepe.2022.100454_bib0043","first-page":"899","article-title":"Alcoholism and risk for cancer of the cervix uteri, vagina, and vulva","volume":"10","author":"Weiderpass","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"8","key":"10.1016\/j.lanepe.2022.100454_bib0044","doi-asserted-by":"crossref","first-page":"e72142","DOI":"10.1371\/journal.pone.0072142","article-title":"Alcohol consumption and viral load are synergistically associated with CIN1","volume":"8","author":"Min","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.lanepe.2022.100454_bib0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41416-018-0273-9","article-title":"Increased risk of second cancers at sites associated with HPV after a prior HPV-associated malignancy, a systematic review and meta-analysis","volume":"120","author":"Gilbert","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.lanepe.2022.100454_bib0046","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.625330","article-title":"HPV-related oropharyngeal cancer and biomarkers based on epigenetics and microbiome profile","volume":"8","author":"Gougousis","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.lanepe.2022.100454_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2020.106399","article-title":"HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010\u20132019","volume":"144","author":"Bruni","year":"2021","journal-title":"Prev Med"},{"issue":"suppl 7","key":"10.1016\/j.lanepe.2022.100454_bib0048","doi-asserted-by":"crossref","first-page":"H46","DOI":"10.1016\/j.vaccine.2013.06.043","article-title":"Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia","volume":"31","author":"Rogovskaya","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.lanepe.2022.100454_bib0049","doi-asserted-by":"crossref","DOI":"10.3402\/ijch.v75.29787","article-title":"Cancer among circumpolar populations: an emerging public health concern","volume":"75","author":"Young","year":"2016","journal-title":"Int J Circumpolar Health"},{"issue":"6","key":"10.1016\/j.lanepe.2022.100454_bib0050","first-page":"5","article-title":"Cancer incidence in Siberia and Russian Far East","volume":"18","year":"2020","journal-title":"SIBIRSKIJ ONKOLOGI\u010cESKIJ \u017dURNAL"},{"issue":"4","key":"10.1016\/j.lanepe.2022.100454_bib0051","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1007\/s13187-012-0383-7","article-title":"Understanding the limits of large datasets","volume":"27","author":"Sanders","year":"2012","journal-title":"J Cancer Educ"}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622200148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S266677622200148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T04:53:49Z","timestamp":1763009629000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S266677622200148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":52,"alternative-id":["S266677622200148X"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2022.100454","relation":{},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors and communities disproportionately affected by cervical cancer in the Russian Federation: A national population-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Europe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lanepe.2022.100454","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100454"}}